Fen Zhang

Prof. Fen Zhang

Zhejiang University College of Medicine First Affiliated Hospital
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 December 2021 in Metabolites
Verified
Journal Article
Open access
PDF file
ZXZhongyang Xie
Zhongyang Xie
LZLingjian Zhang
Lingjian Zhang
ECErmei Chen
Ermei Chen
JLJuan Lu
Juan Lu
LXLanlan Xiao
Lanlan Xiao
LLLanjuan Li
Lanjuan Li
Drug-induced liver injury (DILI) is rare but clinically important due to a high rate of mortality. However, specific biomarkers for diagnosing and predicting the severity and prognosis of DILI are lacking. Here, we used targeted metabolomics to identify and quantify specific types of bile acids that can predict the severity of DILI. A total of 161 DILI patients were enrolled in this prospective cohort study, as well as 31 health controls. A targeted metabolomics method was used to identify 24 types of bile acids. DILI patients were divided into mild, moderate, and severe groups according to disease severity. A multivariate analysis was performed to identify characteristic bile acids. Then the patients were divided into severe and non-severe groups, and logistic regression was used to identify bile acids that could predict DILI severity. Among the enrolled DILI patients, 32 were in the mild group, 90 were in the moderate group, and 39 were in the severe group. Orthogonal partial least squares-discriminant analysis (OPLS-DA) modeling clearly discriminated among the different groups. Among the four groups, glycochenodeoxycholate (GCDCA), taurochenodeoxycholate (TCDCA), deoxycholic acid (DCA), Nor Cholic acid (NorCA), glycocholic acid (GCA), and taurocholic acid (TCA) showed significant differences in concentration between at least two groups. NorCA, GCDCA, and TCDCA were all independent risk factors that differentiated severe DILI patients from the other groups. The area under the receiver operating characteristic curve (AUROC) of GCDCA, TCDCA, and NorCA was 0.856, 0.792, and 0.753, respectively. Together, these three bile acids had an AUROC of 0.895 for predicting severe DILI patients. DILI patients with different disease severities have specific bile acid metabolomics. NorCA, GCDTA, and TCDCA were independent risk factors for differentiating severe DILI patients from less-severe patients and have the potential to predict DILI severity.

15 September 2023 in Hepatology Communications
Verified
Journal Article
Open access
STShima Tang
Shima Tang
JZJunlei Zhang
Junlei Zhang
LZLingjian Zhang
Lingjian Zhang
YZYalei Zhao
Yalei Zhao
LXLanlan Xiao
Lanlan Xiao
LLLanjuan Li
Lanjuan Li
Background: Acute-on-chronic liver failure (ACLF) is an acute decompensated syndrome based on chronic liver disease, while neutrophil recruitment is the most critical early step. C-X-C motif chemokine ligand 1 (CXCL1), a cytokine that recruits neutrophils, was significantly upregulated in both ACLF mice and patients with ACLF. This present study aims to explore the role of CXCL1 in the pathogenesis of ACLF. Methods: We established an ACLF mouse model induced by carbon tetrachloride, lipopolysaccharide, and D-galactosamine, and used adeno-associated virus to achieve overexpression and knockdown of Cxcl1. We employed mass cytometry, flow cytometry, multiplex cytokine and chemokine analysis, Western blot, and reactive oxygen species (ROS) detection in mice blood and liver. ACLF patients (n = 10) and healthy controls (n = 5) were included, and their liver samples were stained using multiplex immunohistochemistry techniques. Results: CXCL1 was significantly elevated in both ACLF mice and patients. CXCL1 recruits neutrophils by binding to the C-X-C motif chemokine receptor 2 on the surface of neutrophils, affects ACLF prognosis by generating ROS and mitochondrial depolarization and modulating caspase3-related apoptotic pathways. We found that the knockdown of CXCL1 attenuated the infiltration of neutrophils in the mouse liver, reduced the expression of inflammatory cytokines, and also significantly downregulated ROS production and caspase3-related hepatocyte apoptosis, thereby ameliorating the liver injury of ACLF. Conclusions: CXCL1 is a core player in the mobilization of neutrophils in ACLF, and the knockdown of Cxcl1 improves neutrophil infiltration, reduces ROS levels, and reduces hepatocyte apoptosis, thereby attenuating inflammation and liver injury in ACLF. Our results revealed a previously unknown link between CXCL1-induced neutrophil recruitment and ACLF, providing evidencing for potential therapies targeting ACLF.

13 August 2015 in Clinical and Experimental Hypertension
Verified
Journal Article
Closed access
PDF file
JZJie Zhuang
Jie Zhuang
yiqiang zhanyiqiang zhan
yiqiang zhan
FZFen Zhang
Fen Zhang
ZTZheng Tang
Zheng Tang
JWJinsong Wang
Jinsong Wang
JYJinming Yu
Jinming Yu
Objective: We aimed to investigate the association between self-reported insomnia and coronary heart diseases in the elderly Chinese population. Methods and results: A cross-sectional study was conducted in the Beijing and 2982 participants aged ≥60 years were recruited. The association between self-reported insomnia and coronary heart diseases (CHD) was determined by multiple logistic regression models. Age, gender, education, obesity, physical activity, current smoking, current drinking, medication, hypertension, diabetes, tea consumption, heart rate, and dyslipidemia were adjusted as confounders. Odds ratios (ORs) and corresponding 95% confidence intervals (CIs) were reported as effect measurements. The numbers of subjects with no insomnia, occasional insomnia, and frequent insomnia were 2110 (70.76%), 509(17.07%), and 363 (12.17%), respectively. The prevalence of CHD in those with no insomnia, occasional insomnia, and frequent insomnia were 13.65%, 16.31%, and 22.31%. Compared with subjects with no insomnia, the multivariate adjusted ORs and 95% CIs for those with occasional insomnia and frequent insomnia were 1.17 (0.89–1.54) and 1.73 (1.30–2.31), respectively. There was no significant difference of the association between men and women. Conclusions: Self-reported insomnia is associated with high risks of CHD in the elderly Chinese population.

17 January 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
Xiao-Xin WuXiao-Xin Wu
Xiao-Xin Wu
STSongjia Tang
Songjia Tang
ZWZhehua Wang
Zhehua Wang
XMXiaoyun Ma
Xiaoyun Ma
LZLingjian Zhang
Lingjian Zhang
KCKe-Da Chen
Ke-Da Chen
Background: Short peptide hydrogel was reported as a possible adjuvant for vaccines. In order to evaluate whether the Tetra-Peptide Hydrogel can be a promising adjuvant for an H7N9 vaccine against the highly pathogenic H7N9 virus, we conducted this study. Methods: Tetra-Peptide Hydrogels (D and L conformations) were prepared by a self-assembly system using a Naproxen acid modified tetra peptide of GFFY (Npx-GFFY). Mice received two immunizations with the D-Tetra-Peptide Hydrogel adjuvant vaccine, the L-Tetra-Peptide Hydrogel adjuvant vaccine, or the split vaccine. Fourteen days following the second dose, the mice were challenged with the highly pathogenic A/Guangdong/GZ8H002/2017(H7N9) virus. The mice were observed for signs of illness, weight loss, pathological alterations of the lung tissues and immune responses in the following 2 weeks. Results: The D/L-Tetra-Peptide Hydrogels resembled long bars with hinges on each other, with a diameter of ~10 nm. The H7N9 vaccine was observed to adhere to the hydrogel. All the unvaccinated mice were dead by 8 days post infection with H7N9. The mice immunized by the split H7N9 vaccine were protected against infection with H7N9. Mice immunized by D/L-Tetra-Peptide Hydrogel adjuvant vaccines experienced shorter symptomatic periods and their micro-neutralization titers were higher than in the split H7N9 vaccine at 2 weeks post infection. The hemagglutinating inhibition (HI) titer in the L-Tetra-Peptide Hydrogel adjuvant vaccine group was higher than that in the split H7N9 vaccine 1 week and 2 weeks post infection. The HI titer in the D-Tetra-Peptide Hydrogel adjuvant vaccine group was higher than that in the split H7N9 vaccine at 2 weeks post infection. Conclusion: The D/L Tetra-Peptide Hydrogels increased the protection of the H7N9 vaccine and could be promising adjuvants for H7N9 vaccines against highly pathogenic H7N9 virus.